Image

Study of Oral Weekly GS-1720 and GS-4182 Versus Biktarvy in People With HIV-1 Who Are Virologically Suppressed

Oral weekly HIV treatment study comparing GS-1720, GS-4182 to Biktarvy.

Recruiting
18 years and older
All
Phase 2/3
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study aims to test new HIV-1 treatments. HIV-1 is a type of virus that attacks the immune system. The study compares two new drugs, GS-1720 and GS-4182, with the current standard treatment called Biktarvy (BVY), which is a mix of three drugs (bictegravir, emtricitabine, and tenofovir alafenamide). The study has two phases:

Phase 2: This part checks how well the new drugs work over 24 weeks.

Phase 3: This part looks at their effectiveness over 48 weeks.

To join, participants must have stable HIV levels, proven by low virus amounts in their blood. They should have been on BVY for at least 24 weeks. Those who have tried similar drugs before or have certain blood test results can't join. The study also excludes people with hepatitis B or C infections.

  • **Duration:** Up to 48 weeks
  • **Visits:** Regular check-ups required
  • **Eligibility:** Stable HIV, no prior similar drug use

Remember, joining a study can help find better treatments, but it's essential to know all the details and risks involved.

Print
Study details
    HIV-1-Infection

NCT06544733

Gilead Sciences

13 December 2024

Contact a study center
Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

  Other languages supported:

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.